https://www.live-feeds.com/feed/glp-1-injections-recalled-nationwide-see-affected-productsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/glp-1-injections-recalled-nationwide-see-affected-productshttps://www.live-feeds.com/feed/glp-1-injections-recalled-nationwide-see-affected-products#u150089Fri, 23 Oct 2026 14:31:05 +0000Federal health officials have issued a nationwide recall affecting multiple vials of compounded GLP-1 injections due to potential sterility issues. The Food and Drug Administration announced the action on compounded tirzepatide products manufactured by Apothecary Pharma. Patients across the United States who use these specific compounded injections are advised to check affected product details, including specific lot numbers, to determine if their medication is subject to the safety recall. The federal health agency previously initiated the action in September before updating the recall to a h